Adjuvant Nivolumab Promising in Resected Merkel Cell Carcinoma
Absolute risk reduction of 9-10% in 1- and 2-year DFS compared with observation
Source: medpagetoday.com
Stay updated with breaking news from Philippe Saiag. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Absolute risk reduction of 9-10% in 1- and 2-year DFS compared with observation